Jazz Pharmaceuticals plc

JAZZ

$137.78

Name : Jazz Pharmaceuticals plc

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $8,357,570,560.00

EPSttm : -6.99

Jazz Pharmaceuticals plc

$137.78

0.33%

$0.46

Float Short %

9.19

Margin Of Safety %

Put/Call OI Ratio

0.17

EPS Next Q Diff

14.83

EPS Last/This Y

-3.76

EPS This/Next Y

16.2

Price

137.78

Target Price

186.56

Analyst Recom

1.21

Performance Q

22.49

Relative Volume

0.58

Beta

0.28

Ticker: JAZZ

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-09-09	JAZZ	128.57	0.16	0.53	12833
2025-09-10	JAZZ	127.3	0.16	0.01	12853
2025-09-11	JAZZ	128.41	0.16	0.00	12980
2025-09-12	JAZZ	126.13	0.15	0.08	13610
2025-09-15	JAZZ	125.18	0.16	0.36	13351
2025-09-16	JAZZ	126.53	0.16	0.05	13923
2025-09-17	JAZZ	129.54	0.16007872724291	0.22222222222222	14146
2025-09-18	JAZZ	131.16	0.16	0.12	14182
2025-09-22	JAZZ	130.22	0.18	0.40	10855
2025-09-23	JAZZ	129.44	0.18	0.15	11032
2025-09-24	JAZZ	129.61	0.18	0.00	11054
2025-09-25	JAZZ	127.87	0.18	0.18	11108
2025-09-26	JAZZ	127	0.18	0.13	11154
2025-09-29	JAZZ	128.99	0.19	0.02	11403
2025-09-30	JAZZ	131.74	0.16	0.06	12835
2025-10-01	JAZZ	136.95	0.15	0.06	14052
2025-10-02	JAZZ	137.18	0.15	0.06	14259
2025-10-03	JAZZ	139.08	0.15	0.09	14403
2025-10-06	JAZZ	137.54	0.16	0.36	14243
2025-10-07	JAZZ	137.23	0.17	0.14	14533
2025-10-08	JAZZ	137.78	0.17	0.01	15831
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-09-09	JAZZ	128.55	-9.8	1556.5	5.30
2025-09-10	JAZZ	126.90	-9.8	1554.3	5.30
2025-09-11	JAZZ	128.46	-9.8	1575.5	5.30
2025-09-12	JAZZ	126.17	-9.8	1550.0	5.30
2025-09-15	JAZZ	125.23	-9.8	1558.8	5.30
2025-09-16	JAZZ	126.54	-9.8	1574.0	5.30
2025-09-17	JAZZ	129.49	-9.8	1584.9	5.30
2025-09-18	JAZZ	131.17	-9.8	1575.8	5.30
2025-09-19	JAZZ	128.29	-9.8	1546.6	5.30
2025-09-22	JAZZ	130.18	-9.8	1577.5	5.30
2025-09-23	JAZZ	129.45	-9.8	1560.2	5.30
2025-09-24	JAZZ	129.58	-9.8	1566.3	5.30
2025-09-25	JAZZ	127.80	-9.8	1553.3	5.30
2025-09-26	JAZZ	127.00	-9.8	1559.8	5.30
2025-09-29	JAZZ	129.02	-9.8	1578.6	5.30
2025-09-30	JAZZ	131.83	-9.8	1583.8	5.30
2025-10-01	JAZZ	136.91	-9.8	1599.3	5.30
2025-10-02	JAZZ	137.26	-9.8	1567.4	5.30
2025-10-03	JAZZ	139.52	-9.8	1579.8	5.30
2025-10-06	JAZZ	137.58	-9.8	1567.4	5.30
2025-10-07	JAZZ	137.24	-9.8	1563.0	5.30
2025-10-08	JAZZ	137.78	-10.3	1568.0	5.30
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-09-09	JAZZ	3.01	3.55	9.74
2025-09-10	JAZZ	3.01	3.55	9.74
2025-09-11	JAZZ	3.01	3.55	9.90
2025-09-12	JAZZ	3.06	3.55	9.90
2025-09-15	JAZZ	3.14	3.53	9.90
2025-09-16	JAZZ	3.14	3.53	9.90
2025-09-17	JAZZ	3.14	3.53	9.90
2025-09-18	JAZZ	3.14	3.53	9.90
2025-09-19	JAZZ	3.14	3.53	9.90
2025-09-22	JAZZ	3.14	3.53	9.90
2025-09-23	JAZZ	3.16	3.53	9.90
2025-09-24	JAZZ	3.16	3.53	9.90
2025-09-25	JAZZ	3.16	3.53	9.19
2025-09-26	JAZZ	3.16	3.53	9.19
2025-09-29	JAZZ	3.16	3.56	9.19
2025-09-30	JAZZ	3.16	3.56	9.19
2025-10-01	JAZZ	3.16	3.56	9.19
2025-10-02	JAZZ	3.16	3.56	9.19
2025-10-03	JAZZ	3.16	3.56	9.19
2025-10-06	JAZZ	3.02	3.52	9.19
2025-10-07	JAZZ	3.02	3.52	9.19
2025-10-08	JAZZ	3.02	3.52	9.19
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-9.07

Avg. EPS Est. Current Quarter

5.96

Avg. EPS Est. Next Quarter

5.76

Insider Transactions

3.02

Institutional Transactions

3.52

Beta

0.28

Average Sales Estimate Current Quarter

1109

Average Sales Estimate Next Quarter

1164

Fair Value

156.53

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

27.1

Max Drawdown 5-Year %

-47.5

Target Price

186.56

P/E

Forward P/E

6.41

PEG

P/S

2.05

P/B

2.25

P/Free Cash Flow

6.61

EPS

-6.75

Average EPS Est. Cur. Y

5.3

EPS Next Y. (Est.)

21.49

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-9.91

Relative Volume

0.58

Return on Equity vs Sector %

-36.1

Return on Equity vs Industry %

-22.5

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

1568

Jazz Pharmaceuticals plc

Sector: Healthcare

Industry: Biotechnology

Employees: 2800

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally. The company offers Xywav to treat cataplexy or excessive daytime sleepiness (EDS) with narcolepsy and idiopathic hypersomnia (IH); Xyrem for the treatment of cataplexy or EDS with narcolepsy; Epidiolex for seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC); Rylaze for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphoma; Enrylaze to treat acute lymphoblastic leukemia and lymphoblastic lymphoma; Zepzelca for the treatment of metastatic small cell lung cancer with disease progression on or after platinum-based chemotherapy; Ziihera to treat HER2-positive biliary tract cancers; Defitelio to treat severe veno-occlusive disease; and Vyxeos for the treatment of newly-diagnosed therapy-related acute myeloid leukemia. It also develops Zanidatamab in Phase 3 trial to treat HER2-expressing gastroesophageal adenocarcinoma (GEA), and patients with HER2-expressing metastatic GEA; Epidiolex in Phase 3 trial to treat LGS, DS, and TSC; Suvecaltamide in Phase 2 trial to treat Parkinson's disease tremor; JZP815, a pan-RAF kinase inhibitor in Phase 1 trial that targets components of the mitogen-activated protein kinase; JZP898, a conditionally activated interferon alpha molecule in Phase 1 trial; JZP441 in Phase 1 trial to treat narcolepsy, IH, and other sleep disorders; JZP324, an extended-release low sodium oxybate formulation in Phase 1 trial for patients with sleep disorders; and JZP150 to treat post-traumatic stress disorder. The company has licensing and collaboration agreements with Redx Pharma plc, Autifony Therapeutics Limited, Zymeworks Inc., Sumitomo Pharma Co., Ltd., and Werewolf Therapeutics, Inc. Jazz Pharmaceuticals plc was founded in 2003 and is headquartered in Dublin, Ireland.

stock quote shares JAZZ – Jazz Pharmaceuticals plc Stock Price stock today

news today JAZZ – Jazz Pharmaceuticals plc stock forecast ,stock prediction 2023 2024 2025

marketwatch JAZZ – Jazz Pharmaceuticals plc yahoo finance google finance

stock history JAZZ – Jazz Pharmaceuticals plc invest stock market

stock prices JAZZ premarket after hours

ticker JAZZ fair value insiders trading

Jazz Pharmaceuticals plc

JAZZ

$137.78

Name : Jazz Pharmaceuticals plc

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $8,357,570,560.00

EPSttm : -6.99

Jazz Pharmaceuticals plc

$137.78

0.33%

$0.46

Float Short %

9.19

Margin Of Safety %

Put/Call OI Ratio

0.17

EPS Next Q Diff

14.83

EPS Last/This Y

-3.76

EPS This/Next Y

16.2

Price

137.78

Target Price

186.56

Analyst Recom

1.21

Performance Q

22.49

Relative Volume

0.58

Beta

0.28

Ticker: JAZZ

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-09-09	JAZZ	128.57	0.16	0.53	12833
2025-09-10	JAZZ	127.3	0.16	0.01	12853
2025-09-11	JAZZ	128.41	0.16	0.00	12980
2025-09-12	JAZZ	126.13	0.15	0.08	13610
2025-09-15	JAZZ	125.18	0.16	0.36	13351
2025-09-16	JAZZ	126.53	0.16	0.05	13923
2025-09-17	JAZZ	129.54	0.16007872724291	0.22222222222222	14146
2025-09-18	JAZZ	131.16	0.16	0.12	14182
2025-09-22	JAZZ	130.22	0.18	0.40	10855
2025-09-23	JAZZ	129.44	0.18	0.15	11032
2025-09-24	JAZZ	129.61	0.18	0.00	11054
2025-09-25	JAZZ	127.87	0.18	0.18	11108
2025-09-26	JAZZ	127	0.18	0.13	11154
2025-09-29	JAZZ	128.99	0.19	0.02	11403
2025-09-30	JAZZ	131.74	0.16	0.06	12835
2025-10-01	JAZZ	136.95	0.15	0.06	14052
2025-10-02	JAZZ	137.18	0.15	0.06	14259
2025-10-03	JAZZ	139.08	0.15	0.09	14403
2025-10-06	JAZZ	137.54	0.16	0.36	14243
2025-10-07	JAZZ	137.23	0.17	0.14	14533
2025-10-08	JAZZ	137.78	0.17	0.01	15831
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-09-09	JAZZ	128.55	-9.8	1556.5	5.30
2025-09-10	JAZZ	126.90	-9.8	1554.3	5.30
2025-09-11	JAZZ	128.46	-9.8	1575.5	5.30
2025-09-12	JAZZ	126.17	-9.8	1550.0	5.30
2025-09-15	JAZZ	125.23	-9.8	1558.8	5.30
2025-09-16	JAZZ	126.54	-9.8	1574.0	5.30
2025-09-17	JAZZ	129.49	-9.8	1584.9	5.30
2025-09-18	JAZZ	131.17	-9.8	1575.8	5.30
2025-09-19	JAZZ	128.29	-9.8	1546.6	5.30
2025-09-22	JAZZ	130.18	-9.8	1577.5	5.30
2025-09-23	JAZZ	129.45	-9.8	1560.2	5.30
2025-09-24	JAZZ	129.58	-9.8	1566.3	5.30
2025-09-25	JAZZ	127.80	-9.8	1553.3	5.30
2025-09-26	JAZZ	127.00	-9.8	1559.8	5.30
2025-09-29	JAZZ	129.02	-9.8	1578.6	5.30
2025-09-30	JAZZ	131.83	-9.8	1583.8	5.30
2025-10-01	JAZZ	136.91	-9.8	1599.3	5.30
2025-10-02	JAZZ	137.26	-9.8	1567.4	5.30
2025-10-03	JAZZ	139.52	-9.8	1579.8	5.30
2025-10-06	JAZZ	137.58	-9.8	1567.4	5.30
2025-10-07	JAZZ	137.24	-9.8	1563.0	5.30
2025-10-08	JAZZ	137.78	-10.3	1568.0	5.30
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-09-09	JAZZ	3.01	3.55	9.74
2025-09-10	JAZZ	3.01	3.55	9.74
2025-09-11	JAZZ	3.01	3.55	9.90
2025-09-12	JAZZ	3.06	3.55	9.90
2025-09-15	JAZZ	3.14	3.53	9.90
2025-09-16	JAZZ	3.14	3.53	9.90
2025-09-17	JAZZ	3.14	3.53	9.90
2025-09-18	JAZZ	3.14	3.53	9.90
2025-09-19	JAZZ	3.14	3.53	9.90
2025-09-22	JAZZ	3.14	3.53	9.90
2025-09-23	JAZZ	3.16	3.53	9.90
2025-09-24	JAZZ	3.16	3.53	9.90
2025-09-25	JAZZ	3.16	3.53	9.19
2025-09-26	JAZZ	3.16	3.53	9.19
2025-09-29	JAZZ	3.16	3.56	9.19
2025-09-30	JAZZ	3.16	3.56	9.19
2025-10-01	JAZZ	3.16	3.56	9.19
2025-10-02	JAZZ	3.16	3.56	9.19
2025-10-03	JAZZ	3.16	3.56	9.19
2025-10-06	JAZZ	3.02	3.52	9.19
2025-10-07	JAZZ	3.02	3.52	9.19
2025-10-08	JAZZ	3.02	3.52	9.19
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-9.07

Avg. EPS Est. Current Quarter

5.96

Avg. EPS Est. Next Quarter

5.76

Insider Transactions

3.02

Institutional Transactions

3.52

Beta

0.28

Average Sales Estimate Current Quarter

1109

Average Sales Estimate Next Quarter

1164

Fair Value

156.53

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

27.1

Max Drawdown 5-Year %

-47.5

Target Price

186.56

P/E

Forward P/E

6.41

PEG

P/S

2.05

P/B

2.25

P/Free Cash Flow

6.61

EPS

-6.75

Average EPS Est. Cur. Y

5.3

EPS Next Y. (Est.)

21.49

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-9.91

Relative Volume

0.58

Return on Equity vs Sector %

-36.1

Return on Equity vs Industry %

-22.5

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

1568

Jazz Pharmaceuticals plc

Sector: Healthcare

Industry: Biotechnology

Employees: 2800

stock quote shares JAZZ – Jazz Pharmaceuticals plc Stock Price stock today

news today JAZZ – Jazz Pharmaceuticals plc stock forecast ,stock prediction 2023 2024 2025

marketwatch JAZZ – Jazz Pharmaceuticals plc yahoo finance google finance

stock history JAZZ – Jazz Pharmaceuticals plc invest stock market

stock prices JAZZ premarket after hours

ticker JAZZ fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: JAZZ

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: JAZZ

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y